Open access · CC-BY
via OpenAlex
Intermediate cells of in vitro cellular reprogramming and in vivo tissue regeneration require desmoplakin
Jeongmin Ha, Bum Suk Kim, Byungkuk Min, Juhyeon Nam, Jae-Geun Lee, Minhyung Lee, Byoung-Ha Yoon, Yoon Ha Choi, Ilkyun Im, Jung Sun Park, Hyosun Choi, Areum Baek, Sang Mi Cho, Mi‐Ok Lee, Ki‐Hoan Nam
Science Advances · 2022 · ▲ 14 citations
Abstract
Amphibians and fish show considerable regeneration potential via dedifferentiation of somatic cells into blastemal cells. In terms of dedifferentiation, in vitro cellular reprogramming has been proposed to share common processes with in vivo tissue regeneration, although the details are elusive. Here, we identified the cytoskeletal linker protein desmoplakin (Dsp) as a common factor mediating both reprogramming and regeneration. Our analysis revealed that Dsp expression is elevated in distinct intermediate cells during in vitro reprogramming. Knockdown of Dsp impedes in vitro reprogramming into induced pluripotent stem cells and induced neural stem/progenitor cells as well as in vivo regeneration of zebrafish fins. Notably, reduced Dsp expression impairs formation of the intermediate cells during cellular reprogramming and tissue regeneration. These findings suggest that there is a Dsp-mediated evolutionary link between cellular reprogramming in mammals and tissue regeneration in lower vertebrates and that the intermediate cells may provide alternative approaches for mammalian regenerative therapy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1126/sciadv.abk1239
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Ha, J., Kim, B.S., Min, B., Nam, J., Lee, J., Lee, M., Yoon, B., Choi, Y.H., Im, I., Park, J.S., Choi, H., Baek, A., Cho, S.M., Lee, M., Nam, K., Mun, J.Y., Kim, S., Son, M., Kang, Y., & Lee, J. (2022). Intermediate cells of in vitro cellular reprogramming and in vivo tissue regeneration require desmoplakin. <em>Science Advances</em>. https://doi.org/10.1126/sciadv.abk1239
Vancouver
Ha J, Kim BS, Min B, Nam J, Lee J, Lee M, et al. Intermediate cells of in vitro cellular reprogramming and in vivo tissue regeneration require desmoplakin. Science Advances. 2022. doi:10.1126/sciadv.abk1239.
BibTeX
@article{jeongmin2022Interm,
title = {Intermediate cells of in vitro cellular reprogramming and in vivo tissue regeneration require desmoplakin},
author = {Jeongmin Ha and Bum Suk Kim and Byungkuk Min and Juhyeon Nam and Jae-Geun Lee and Minhyung Lee and Byoung-Ha Yoon and Yoon Ha Choi and Ilkyun Im and Jung Sun Park and Hyosun Choi and Areum Baek and Sang Mi Cho and Mi‐Ok Lee and Ki‐Hoan Nam and Ji Young Mun and Seon‐Young Kim and Mi‐Young Son and Yong‐Kook Kang and Jeong-Soo Lee and Jong Kyoung Kim and Janghwan Kim},
journal = {Science Advances},
year = {2022},
doi = {10.1126/sciadv.abk1239},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Development 2022
Open access · CC-BY
Natural killer cells act as an extrinsic barrier for in vivo reprogramming
World Journal of Stem Cells 2019
Open access · CC-BY
Human adult pluripotency: Facts and questions
Cancer Science 2018
Open access · CC-BY
Unveiling epigenetic regulation in cancer, aging, and rejuvenation with in vivo reprogramming technology
Stem Cell Reports 2022
Open access · CC-BY
Deciphering the roadmap of in vivo reprogramming toward pluripotency
bioRxiv (Cold Spring Harbor Laboratory) 2019
Preprint · OA
Transient Reprogramming of Neonatal Cardiomyocytes to a Proliferative Dedifferentiated State
Journal of Advanced Research 2025
Open access · CC-BY